Trazodone Tablets

Developed to target depressive disorders, utilized to support patients to alleviate symptoms of low mood and anxiety through regulated serotonin modulation.

Strengths: 25 · 50 · 100mg

Medicine details

Alternative names

Molipaxin

Therapeutic class

antidepressant

Pharmacological class

serotonin antagonist and reuptake inhibitor (SARI)

Known off-label uses

insomnia

Contraindications

acute recovery phase of myocardial infarction; hypersensitivity

Precautions and warnings

may cause drowsiness

Minor side effects

drowsiness; dry mouth

Moderate side effects

dizziness; headache; nausea

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

Sanofi

Onset Time

1–2 weeks

Duration

Half-life ~7 hours

Storage instructions

Store below 25°C.

Drug interactions

alcohol; fluoxetine; monoamine oxidase inhibitors

Age restrictions

Not for children and adolescents under 18 years.

Pregnancy and breastfeeding

Pregnancy: use with caution. Breastfeeding: use with caution.

Serious side effects

priapism — requires immediate medical attention; serotonin syndrome — requires immediate medical attention

Patient summary

Developed to target depressive disorders, utilized to support patients to alleviate symptoms of low mood and anxiety through regulated serotonin modulation.

Mechanism of action

Trazodone is a serotonin antagonist and reuptake inhibitor. It inhibits the reuptake of serotonin presynaptically while also antagonising 5-HT2A receptors. This dual-action approach helps to improve mood and sleep patterns.

Trazodone Tablets

Developed to target depressive disorders, utilized to support patients to alleviate symptoms of low mood and anxiety through regulated serotonin modulation.

Editorial Notes

  • Active ingredient(s): Trazodone
  • Listed indication(s): Major Depressive Disorder, Anxiety

Usually available as

  • 360 tablets - 25 mg1164-25-mg-13758
  • 360 tablets - 50 mg1164-50-mg-13764
  • 120 tablets - 100 mg1164-100-mg-13768